Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor
Kaye, Joel, Piryatinsky, Victor, Birnberg, Tal, Hingaly, Tal, Raymond, Emanuel, Kashi, Rina, Amit-Romach, Einat, Caballero, Ignacio S., Towfic, Fadi, Ator, Mark A., Rubinstein, Efrat, Laifenfeld, Daphna, Orbach, Aric, Shinar, Doron, Marantz, Yael, Grossman, Iris, Knappertz, Volker, Hayden, Michael R., Laufer, Ralph
Published in Proceedings of the National Academy of Sciences - PNAS (11.10.2016)
Published in Proceedings of the National Academy of Sciences - PNAS (11.10.2016)
Get full text
Journal Article
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis
Comi, Giancarlo, Dadon, Yuval, Sasson, Nissim, Steinerman, Joshua R, Knappertz, Volker, Vollmer, Timothy L, Boyko, Alexey, Vermersch, Patrick, Ziemssen, Tjalf, Montalban, Xavier, Lublin, Fred D, Rocca, Maria A, Volkinshtein, Rita, Rubinchick, Svetlana, Halevy, Nitsan, Filippi, Massimo
Published in Multiple sclerosis (01.04.2022)
Published in Multiple sclerosis (01.04.2022)
Get more information
Journal Article
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
O'Connor, Paul, MD, Filippi, Massimo, MD, Arnason, Barry, MD, Comi, Giancarlo, MD, Cook, Stuart, MD, Goodin, Douglas, MD, Hartung, Hans-Peter, MD, Jeffery, Douglas, MD, Kappos, Ludwig, MD, Boateng, Francis, PhD, Filippov, Vitali, PhD, Groth, Maria, MD, Knappertz, Volker, MD, Kraus, Christian, MD, Sandbrink, Rupert, MD, Pohl, Christoph, MD, Bogumil, Timon, MD
Published in Lancet neurology (01.10.2009)
Published in Lancet neurology (01.10.2009)
Get full text
Journal Article
Causes of death among commercially insured multiple sclerosis patients in the United States
Goodin, Douglas S, Corwin, Michael, Kaufman, David, Golub, Howard, Reshef, Shoshana, Rametta, Mark J, Knappertz, Volker, Cutter, Gary, Pleimes, Dirk
Published in PloS one (21.08.2014)
Published in PloS one (21.08.2014)
Get full text
Journal Article
A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
Ross, Colin J, Towfic, Fadi, Shankar, Jyoti, Laifenfeld, Daphna, Thoma, Mathis, Davis, Matthew, Weiner, Brian, Kusko, Rebecca, Zeskind, Ben, Knappertz, Volker, Grossman, Iris, Hayden, Michael R
Published in Genome medicine (31.05.2017)
Published in Genome medicine (31.05.2017)
Get full text
Journal Article
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS
Goodin, Douglas S, Jones, Jason, Li, David, Traboulsee, Anthony, Reder, Anthony T, Beckmann, Karola, Konieczny, Andreas, Knappertz, Volker
Published in PloS one (30.11.2011)
Published in PloS one (30.11.2011)
Get full text
Journal Article
Sample Size Estimates for Clinical Trials of Vasospasm in Subarachnoid Hemorrhage
KREITER, Kurt T, MAYER, Stephan A, HOWARD, George, KNAPPERTZ, Volker, ILODIGWE, Don, SLOAN, Michael A, MACDONALD, R. Loch
Published in Stroke (1970) (01.07.2009)
Published in Stroke (1970) (01.07.2009)
Get full text
Journal Article
Potential Health Care Cost Savings Associated With Early Treatment of Multiple Sclerosis Using Disease-Modifying Therapy
Curkendall, Suellen M., PhD, Wang, Cheng, MD, PhD, Johnson, Barbara H., MBA, Cao, Zhun, PhD, Preblick, Ronald, PharmD, MPH, Torres, Amelito M., MBA, Knappertz, Volker, MD, Gondek, Kathleen, PhD
Published in Clinical therapeutics (01.07.2011)
Published in Clinical therapeutics (01.07.2011)
Get full text
Journal Article
Once‐daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing–remitting multiple sclerosis
Yamamura, Takashi, Ashtamker, Natalia, Ladkani, David, Fukazawa, Toshiyuki, Houzen, Hideki, Tanaka, Masami, Miura, Toshiro, Knappertz, Volker
Published in Clinical & experimental neuroimmunology (01.05.2017)
Published in Clinical & experimental neuroimmunology (01.05.2017)
Get full text
Journal Article
Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis
Caloyeras, John P., MPhil, Zhang, Bin, MD, MSc, Wang, Cheng, MD, PhD, Eriksson, Marianne, MSc, Fredrikson, Sten, MD, PhD, Beckmann, Karola, MSc, Knappertz, Volker, MD, Pohl, Christoph, MD, Hartung, Hans-Peter, MD, Shah, Dhvani, MS, Miller, Jeffrey D., MS, Sandbrink, Rupert, MD, Lanius, Vivian, PhD, Gondek, Kathleen, PhD, Russell, Mason W., MAPE
Published in Clinical therapeutics (01.05.2012)
Published in Clinical therapeutics (01.05.2012)
Get full text
Journal Article
Early impairment in consciousness predicts mortality after hemispheric ischemic stroke
Cucchiara, Brett L, Kasner, Scott E, Wolk, David A, Lyden, Patrick D, Knappertz, Volker A, Ashwood, Tim, Odergren, Tomas, Nordlund, Anders
Published in Critical care medicine (01.01.2004)
Published in Critical care medicine (01.01.2004)
Get more information
Journal Article
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial
Miller, Ian, Scheffer, Ingrid E, Gunning, Boudewijn, Sanchez-Carpintero, Rocio, Gil-Nagel, Antonio, Perry, M Scott, Saneto, Russell P, Checketts, Daniel, Dunayevich, Eduardo, Knappertz, Volker
Published in Archives of neurology (Chicago) (01.05.2020)
Published in Archives of neurology (Chicago) (01.05.2020)
Get full text
Journal Article
Mortality in patients with multiple sclerosis
Scalfari, Antonio, Knappertz, Volker, Cutter, Gary, Goodin, Douglas S, Ashton, Raymond, Ebers, George C
Published in Neurology (09.07.2013)
Published in Neurology (09.07.2013)
Get more information
Journal Article
Pharmacodynamic synergism contributes to the antiseizure action of cannabidiol and clobazam
Rana, Rohini R., Rajasekaran, Karthik, Knappertz, Volker, Gray, Royston A.
Published in Experimental neurology (01.02.2023)
Published in Experimental neurology (01.02.2023)
Get full text
Journal Article